Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBG for Oral Mucositis in Head and Neck Cancer
NCT00790322Phase 3Completed
- Sponsor
- Biotec Pharmacon ASA
- Start
- Oct 2008
- Primary completion
- Feb 2010
- Modality
- Polysaccharide, Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of Soluble Beta-Glucan in oral mucositis (OM), sponsored by Biotec Pharmacon ASA. Started Oct 2008; status: completed.
02
Drugs
Soluble Beta-Glucan
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00790322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790322.